期刊文献+

p14ARF增强顺铂诱导的骨肉瘤U2OS细胞凋亡的研究 被引量:3

The effects of p14ARF on cisplatin-induced apoptosis in human osteosarcoma U2OS cells
原文传递
导出
摘要 目的探讨p14ARF对顺铂诱导骨肉瘤U2OS细胞凋亡的影响及其机制,为提高骨肉瘤化疗敏感性提供依据。方法在不表达p14ARF的U2OS细胞中稳定转染pcDNA3.1-p14ARF质粒,构建稳定表达株;采用RT-PCR和Western blot法鉴定其表达;台盼蓝拒染法测定生长抑制作用;Hoechst33258荧光染色检测凋亡;Western blot法检测Caspase-3,9和PARP的表达和活化。结果 mRNA和蛋白水平,U2OS和U2OS-vec细胞未见p14ARF表达,U2OS-ARF细胞可见p14ARF的高表达;p14ARF单独对U2OS细胞的生长无影响,但顺铂(5μM)处理72小时后,U2OS-ARF细胞的生长抑制率明显高于U2OS和U2OS-vec细胞,相对于U2OS和U2OS-vec细胞,U2OS-ARF细胞不仅表现更为明显的凋亡形态学变化,还明显出现了Caspase-3,9和PARP的活化裂解。结论 p14ARF能够增强顺铂诱导的骨肉瘤U2OS细胞毒作用和凋亡,通过激活Caspase-PARP级联活化,提高骨肉瘤U2OS细胞对顺铂的敏感性。 Objective To study the effects of p14ARF on cisplatin-induced apoptosis in human osteosarcoma U2OS cells with its molecular mechanisms and to provide evidences for increasing chemosensitivity of osteosarcoma.Methods pcDNA3.1-p14ARF plasmid was stably transfected into U2OS cells that did not express p14ARF.Expression of p14ARF on mRNA and protein level was detected by RT-PCR and Western blot.Growth inhibition rate was evaluated using trypan blue exclusion assay.Apoptosis was studied using Hoechst 33258 staining.Activation of Caspase-3,9 and PARP was detected by Western blot.Results There was no expression of p14ARF in U2OS and U2OS-vec cells but obvious expression was observed in U2OS-ARF cells on mRNA and protein level.p14ARF alone had no influence on growth of U2OS cells.Compared with U2OS and U2OS-vec cells,there were higher cell inhibition rate,more obvious apoptotic morphological changes,and higher level of Caspase-3,9 and PARP activation in U2OS-ARF cells after treatment with cisplatin(5μM) for 72h.Conclusions p14ARF enhances cisplatin-induced growth inhibition and apoptosis in human osteosarcoma U2OS cells by activation of caspases-PARP cascade.This work can be exploited to increase the chemosensitivity of osteosarcoma.
出处 《中华关节外科杂志(电子版)》 CAS 2010年第6期50-53,共4页 Chinese Journal of Joint Surgery(Electronic Edition)
基金 广东省医学科研基金项目(B2009249) 江门市科技计划项目(江科20084029)
关键词 肿瘤抑制基因p14ARF 顺铂 骨肉瘤 细胞凋亡 化疗敏感性 Tumor suppressor gene pldARF Cisplatin Osteosarcoma Apoptosis Chemosensitivity
  • 相关文献

参考文献14

  • 1Mao L, Medo A, Bedi G, et al. A novel p16INK4A transcript. Cancer Res, 1995, 55 (14) : 2995 -2997.
  • 2Quene DE, Zindy F, Ashmun RA, et al, Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 1995, 83 (6) : 993 - 1000.
  • 3de Stanchina E, McCurrach ME, Zindy F, et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. Genes Dev, 1998, 12 (15) : 2434 -2442.
  • 4Guo-Chang F, Chu-Tse W. Transfer of p14ARF gene in drugresistant human breast MCF-7/Adr cells inhibits proliferation and reduces doxorubicin resistance. Cancer Lett, 2000, 158 (2) : 203 -210.
  • 5郭卫.恶性骨肿瘤保肢治疗的原则及问题[J].中华关节外科杂志(电子版),2007,1(5):257-260. 被引量:13
  • 6李浩淼,沈靖南.骨关节假体在四肢恶性骨肿瘤保肢手术中的应用[J].中华关节外科杂志(电子版),2007,1(5):319-320. 被引量:2
  • 7Park YB, Park MJ, Kimura K, et al. Alterations in the INK4a/ ARF locus and their effects on the growth of human osteosarcoma cell lines. Cancer Genet Cytogenet, 2002, 133 (2): 105- 111.
  • 8Sheer CJ. Autophagy by ARF : a short story. Mol Cell, 2006, 22 : 436 - 437.
  • 9Oh JH, Kim HS, Kim HH, et al. Aberrant methylation of p14ARF gene correlates with poor survival in osteosarcoma. Clin Orthop Relat Res, 2006(442) : 216 -222.
  • 10Hemmati PG, Gillissen B, von Haefen C, et al. Adenovirusmediated overexpression of p14 ( ARF ) induces p53 and Baxindependent apoptosis. Oncogene, 2002, 21 (20) : 3149 - 3161.

二级参考文献14

  • 1A. M. Davis,J. G. Wright,J. I. Williams,C. Bombardier,A. Griffin,R. S. Bell. Development of a measure of physical function for patients with bone and soft tissue sarcoma[J] 1996,Quality of Life Research(5):508~516
  • 2Jaffe N,Frei E,Watts H,et al.High-dose methotrexate in osteogenic sarcoma:a5-year experience[].Cancer Treatment Reports.1978
  • 3Rosen G,Caparros B,Huvos AG,et al.Preoprative chemotherapy for osteogenic sarcoma:selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy[].Cancer.1982
  • 4Meyers PA,Heller G,Healey JH,et al.Chemotherapy for nonmetastatic osteogenic sarcoma:the memorial sloan-kettering experience[].Journal of Clinical Oncology.1992
  • 5Meyers PA,Gorlick R,Heller G,et al.Intensification of preoperative chemotherapy for osteogenic sarcoma:results of the memorial sloan-kettering(T12)protocal[].Journal of Clinical Oncology.1998
  • 6Griffin AM,Parsons JA,Davis AM,et al.Uncemented tumor endoprostheses at the knee[].Clinical Orthopaedics.2005
  • 7Enneking WF.A system of staging musculoskeletal neoplasms[].Clinical Orthopaedics.1986
  • 8Rosen G,Marcove RC,Caparros B,et al.Primary osteogenic sarcoma:the rationale for preoperative chemotherapy and delayed surgery[].Cancer.1979
  • 9Picci P,Sangiorgi L,Rougraff BT,et al.Relationship ofchemotherapy-induced necrosis and surgical margins to localrecurrence in osteosarcoma[].Journal of Clinical Oncology.1994
  • 10Mankin HJ,Gebhardt MC,Jennings LC,et al.Long-term results of allograft replacement in the management of bone tumors[].Clinical Orthopaedics and Related Research.1996

共引文献13

同被引文献34

  • 1郭静,蒲咏梅,张东才.钙离子信号与细胞凋亡[J].生物物理学报,2005,21(1):1-18. 被引量:53
  • 2Botter SM, Neri D, Fuchs B. Recent advances in osteosarcoma [J]. Curr Opin Pharmaeol, 2014, 16: 15-23.
  • 3Mao L, Merlo A, Bedi G, et al. A novel pl6INK4A transcript [J]. Cancer Res, 1995, 559: 2995-2997.
  • 4Oh JH, Kim HS, Kim HH, et al. Aberrant methylation of pl4ARF gene correlates with poor survival in osteosarcoma [ J ]. Clin Orthop Relat Res, 2006, 442: 216-222.
  • 5Ozenne P, Eymin B, Brambilla E, et al. The ARF tumor suppressor: structure, functions and status in cancer [J ]. Int J Cancer, 2010, 127: 2239-2247.
  • 6Park YB, Park MJ, Kimura K, et al. Alterations in the INK4a/ ARF locus and their effects on the growth of human osteosarcoma cell lines[J]. Cancer Genet Cytogenet, 2002, 133: 105-111.
  • 7A1-Mohanna MA, Manogaran PS, A1-Mukhalafi Z, et al. The tumor suppressor p16 (INK4a) gene is a regulator of apoptosis induced by uhraviolet light and cisplatin [ J ]. Oncogene, 2004, 23 : 201-212.
  • 8Gill J, Ahluwalia MK, Geller D, et al. New targets and approaches in osteosareoma[J]. Pharmacol Ther, 2013, 137: 89-99.
  • 9Jung YS, Lee SJ, Lee SH, et al. Loss of VHL promotes progerin expression, leading to impaired pl4/ARF function and suppression of p53 activity[J]. Cell Cycle, 2013, 12: 2277-2290.
  • 10Kolenko VM, Uzzo RG, Bukowski R, et al. Caspase-dependent and -independent death pathways in cancer therapy [ J ]. Apoptosis, 2000, 5 : 17-20.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部